Aseptic Ampoule Filling Line for High Precision Vaccine and Biologics EU GMP Compliant, 99.9% Sterility Assurance
Revolutionize Your Sterile Ampoule Production with Smart Aseptic Filling
The Aseptic Ampoule Filling Line is engineered to meet Europe’s stringent pharmaceutical standards, combining cutting-edge isolator technology with AI-driven process control. Designed for critical applications like mRNA vaccines and monoclonal antibodies, this line ensures 99.9% sterility assurance through HEPA-filtered laminar airflow and real-time particulate monitoring.
Why European Clients Choose This Line:
✅ Zero Cross-Contamination – Closed-system RABS (Restricted Access Barrier System) with glove ports for operator safety.
✅ Adaptive Format Switching – Automatically adjusts between 1ml insulin ampoules and 20ml diagnostic reagents in ≤3 minutes.
✅ Green Manufacturing – Heat recovery from sterilization tunnels reduces energy waste by 18%.
✅ Blockchain Traceability – Embedded IoT sensors log every ampoule’s fill weight, seal integrity, and sterilization parameters for EU MDR compliance.
Aseptic Ampoule Filling Line Spec:
| technical parameters | ||||
| product model | LYQCL100+LYASMR 620/43+LYAGF8 |
|||
| size range | 1-20ml national standard ampoules | |||
| Output(1-2ml) | 16000-22000pcs/h | |||
| Output(5-10ml) | 8000-12000pcs/h | |||
| Output(20ml) | 5000-7000pcs/h | |||
| Clarity | >99% | |||
| Breakage rate | ≤1%(whole line) | |||
| Filling Precision | ±0.5-2%(according to pharmacopoeia standard) | |||
| Water Consumption and Pressure | 0.2-0.4Mpa / 0.6-1.0m³/h | |||
| Cleaning CA Consumption and Pressure | 0.3-0.6Mpa / 35-80m³/h 0.3-1.0Mpa / 35-80m³/h | |||
| Sealed gas | Gas(liquefied gas)+oxygen, oxyhydrogen generation gas, natural gas | |||
| Oxygen consumption | 0.2-0.3Mpa,1.2-1.5m³/h | |||
| Gas consumption | 0.1-0.3Mpa,1.5-2.5m³/h | |||
| Exhaust volume | 3500-4100m³/h | |||
| Net weight | 7800(kg) | |||
| Total power | around 72kw 380V 50HZ | |||
| Outline size | around 9940x2260x2445mm | |||
![]()
![]()
![]()
Real-World Application Spotlight
A Swiss biotech firm reduced fill-loss by 37% using this line’s pulsed volumetric filling technology, crucial for €10,000+/liter gene therapies. The machine’s anti-vibration platform also minimized liquid splashing during high-speed filling of adjuvanted flu vaccines.
Technical Edge